| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| ALNYAlnylam Pharmaceuticals, Inc. | 44.07B | 332.92 | 142.88 | 65.19% | 8.45% | 39.76% | 1.06% | 3.76 |
| SLXNWSilexion Therapeutics Ltd. | 63.6M | 0.03 | 0.00 | -132.54% | ||||
| EDITEditas Medicine, Inc. | 205.18M | 2.20 | -0.76 | -58.64% | -430.84% | -14.85% | 0.26 | |
| SGMOSangamo Therapeutics, Inc. | 92.01M | 0.43 | -0.88 | -67.2% | -331.28% | -17.44% | 1.34 | |
| CAMPCAMP4 Therapeutics Corporation | 210.49M | 4.49 | -1.69 | 86.29% | -14.04% | -133.54% | 0.14 | |
| SLNSilence Therapeutics plc | 256.95M | 5.44 | -1.71 | 70.47% | -252.16% | -84.61% | 0.00 | |
| PEPGPepGen Inc. | 202.89M | 6.22 | -2.18 | -57.35% | 0.16 | |||
| ARCTArcturus Therapeutics Holdings Inc. | 224.14M | 8.23 | -2.74 | -12.27% | -72.48% | -29.71% | 0.12 |
Analyze head-to-head performance against top industry competitors across valuation, growth, and profitability metrics.
| Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 7.01M | 6.48M | 10.88M | 22.24M | 24.29M | 115.53M | 25.1M | 48.73M | 68.7M |
| Revenue Growth % | - | -7.57% | 67.84% | 104.34% | 9.21% | 375.72% | -78.28% | 94.15% | 40.98% |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - |
| Gross Profit | 7.01M | 6.48M | 10.88M | 22.24M | 24.29M | 115.53M | 25.1M | 48.73M | 68.7M |
| Gross Margin % | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% |
| Gross Profit Growth % | - | -7.57% | 67.84% | 104.34% | 9.21% | 375.72% | -78.28% | 94.15% | 40.98% |
| Operating Expenses | 15.2M | 28.34M | 58.8M | 109.44M | 134.11M | 154.91M | 87.41M | 92.46M | 94.86M |
| OpEx % of Revenue | 216.72% | 437.08% | 540.25% | 492.14% | 552.25% | 134.08% | 348.26% | 189.76% | 138.08% |
| Selling, General & Admin | 6.1M | 8.02M | 13.67M | 27.03M | 36.05M | 39.67M | 41.28M | 39.09M | 35.3M |
| SG&A % of Revenue | 86.97% | 123.63% | 125.64% | 121.53% | 148.45% | 34.34% | 164.49% | 80.22% | 51.38% |
| Research & Development | 9.1M | 20.32M | 45.12M | 82.42M | 98.06M | 115.24M | 46.12M | 53.38M | 59.56M |
| R&D % of Revenue | 129.75% | 313.45% | 414.61% | 370.61% | 403.79% | 99.75% | 183.77% | 109.54% | 86.7% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -8.83M | -21.97M | -47.91M | -87.2M | -109.83M | -39.38M | -62.31M | -43.74M | -26.16M |
| Operating Margin % | -125.84% | -338.9% | -440.25% | -392.14% | -452.25% | -34.08% | -248.26% | -89.76% | -38.08% |
| Operating Income Growth % | - | -148.91% | -118.04% | -82.01% | -25.94% | 64.15% | -58.24% | 29.81% | 40.18% |
| EBITDA | -8.19M | -20.54M | -45.56M | -81.89M | -100.02M | -29.18M | -53.3M | -35.48M | -21.59M |
| EBITDA Margin % | -116.72% | -316.76% | -418.62% | -368.23% | -411.84% | -25.26% | -212.38% | -72.82% | -31.42% |
| EBITDA Growth % | - | -150.84% | -121.81% | -79.74% | -22.14% | 70.83% | -82.68% | 33.44% | 39.16% |
| D&A (Non-Cash Add-back) | 640K | 1.44M | 2.35M | 5.32M | 9.81M | 10.2M | 9M | 8.26M | 4.58M |
| EBIT | -8.26M | -21.86M | -46.04M | -92.69M | -109.01M | -30.47M | -71.8M | -40.3M | 8.95M |
| Net Interest Income | 0 | 872K | 1.88M | 4.08M | 822K | 76K | 2.36M | 5.46M | 4.98M |
| Interest Income | 570K | 872K | 1.88M | 4.27M | 822K | 208K | 3.47M | 7.69M | 6.76M |
| Interest Expense | 0 | 0 | 0 | 182K | 0 | 132K | 1.11M | 2.23M | 1.78M |
| Other Income/Expense | 572K | 872K | 1.88M | -5.67M | 822K | 8.77M | -10.6M | 1.21M | 33.33M |
| Pretax Income | -8.26M | -21.1M | -46.04M | -92.88M | -109.01M | -30.6M | -72.91M | -42.53M | 7.17M |
| Pretax Margin % | -117.69% | -325.45% | -423.02% | -417.65% | -448.86% | -26.49% | -290.5% | -87.28% | 10.43% |
| Income Tax | -5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 99.94% | 100% | 100% | 100% | 100% | 100% | 153.12% | 144.19% | 100% |
| Net Income | -8.25M | -21.1M | -46.04M | -92.88M | -109.01M | -30.6M | -111.64M | -61.32M | 7.17M |
| Net Margin % | -117.62% | -325.45% | -423.02% | -417.65% | -448.86% | -26.49% | -444.8% | -125.84% | 10.43% |
| Net Income Growth % | - | -155.75% | -118.16% | -101.74% | -17.37% | 71.93% | -264.8% | 45.07% | 111.69% |
| Net Income (Continuing) | -8.25M | -21.1M | -46.04M | -92.88M | -109.01M | -30.6M | -72.91M | -42.53M | 7.17M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | -38.73M | -18.79M | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.49 | -18.81 | -28.17 | -59.50 | -62.85 | -15.60 | -38.10 | -15.96 | 1.04 |
| EPS Growth % | - | -3738.78% | -49.76% | -111.22% | -5.63% | 75.18% | -144.23% | 58.11% | 106.52% |
| EPS (Basic) | -0.49 | -18.81 | -28.17 | -59.50 | -62.85 | -15.60 | -38.10 | -15.96 | 1.05 |
| Diluted Shares Outstanding | 16.74M | 1.12M | 1.63M | 1.4M | 1.73M | 1.96M | 2.93M | 3.84M | 6.88M |
| Basic Shares Outstanding | 16.74M | 1.12M | 1.63M | 1.4M | 1.73M | 1.96M | 2.93M | 3.84M | 6.83M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - |
| Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 94.4M | 64.33M | 115.67M | 193.67M | 105.56M | 161.75M | 199.1M | 136.36M | 94.99M |
| Cash & Short-Term Investments | 93.42M | 62.8M | 103.19M | 180.89M | 89.8M | 143.66M | 189.58M | 116.68M | 86.31M |
| Cash Only | 93.42M | 62.8M | 103.19M | 180.89M | 89.8M | 143.66M | 189.58M | 116.68M | 85.9M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 413K |
| Accounts Receivable | 386K | 22K | 523K | 965K | 10M | 488K | 720K | 12.8M | 1.7M |
| Days Sales Outstanding | 20.08 | 1.24 | 17.54 | 15.84 | 150.3 | 1.54 | 10.47 | 95.87 | 9.02 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 0 | 70K | 3.05M | 2.32M | 4K | 169K | 2.78M | 906K | 538K |
| Total Non-Current Assets | 4.01M | 8.35M | 22.93M | 41.56M | 44.59M | 49.74M | 39.06M | 23.42M | 41.4M |
| Property, Plant & Equipment | 3.54M | 8.14M | 21.15M | 39.57M | 41.5M | 29.33M | 13.78M | 14.6M | 10.18M |
| Fixed Asset Turnover | 1.98x | 0.80x | 0.51x | 0.56x | 0.59x | 3.94x | 1.82x | 3.34x | 6.75x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 90K | 1.47M | 1.43M | 1.37M | 2.05M | 731K | 400K | 622K |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 6.84M | 4.75M | 3.21M | 3.21M |
| Other Non-Current Assets | 468K | 124K | 312K | 558K | 1.72M | 11.52M | 19.81M | 5.21M | 27.39M |
| Total Assets | 98.41M | 72.68M | 138.6M | 235.23M | 150.16M | 211.5M | 238.17M | 159.78M | 136.39M |
| Asset Turnover | 0.07x | 0.09x | 0.08x | 0.09x | 0.16x | 0.55x | 0.11x | 0.30x | 0.50x |
| Asset Growth % | - | -26.15% | 90.69% | 69.72% | -36.17% | 40.85% | 12.61% | -32.91% | -14.64% |
| Total Current Liabilities | 8.34M | 9.2M | 14.07M | 26.93M | 42.83M | 35.98M | 59.66M | 49.99M | 14.98M |
| Accounts Payable | 1.29M | 1.81M | 2.22M | 2.04M | 792K | 1.14M | 653K | 2.97M | 1.31M |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 22.41M | 0 |
| Deferred Revenue (Current) | 6.21M | 5.82M | 8.44M | 16.49M | 30.24M | 21.24M | 46.19M | 12.04M | 2.96M |
| Other Current Liabilities | 845K | 590K | 2.46M | 6.01M | 6.6M | 7.74M | 9.31M | 9.88M | 7.38M |
| Current Ratio | 11.32x | 6.99x | 8.22x | 7.19x | 2.46x | 4.50x | 3.34x | 2.73x | 6.34x |
| Quick Ratio | 11.32x | 6.99x | 8.22x | 7.19x | 2.46x | 4.50x | 3.34x | 2.73x | 6.34x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 94.82M | 89.85M | 84.56M | 69.99M | 62.9M | 84.35M | 118.07M | 90.93M | 65.02M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 2.48M | 22.22M | 0 | 22.32M |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 8.59M | 4.81M | 1.06M | 7.72M | 6.4M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 433K | 1.25M | 1.76M | 4.09M | 392K | 44K | 1.92M | 128K | 2.99M |
| Total Liabilities | 103.16M | 99.05M | 98.64M | 96.92M | 105.73M | 120.33M | 177.74M | 140.92M | 80M |
| Total Debt | 0 | 0 | 0 | 0 | 10.52M | 9.11M | 24.96M | 31.27M | 30.05M |
| Net Debt | -93.42M | -62.8M | -103.19M | -180.89M | -79.28M | -134.55M | -164.62M | -85.41M | -55.85M |
| Debt / Equity | - | - | - | - | 0.24x | 0.10x | 0.41x | 1.66x | 0.53x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | -479.14x | - | -298.30x | -56.08x | -19.61x | -14.68x |
| Total Equity | -4.75M | -26.37M | 39.96M | 138.31M | 44.42M | 91.17M | 60.43M | 18.86M | 56.39M |
| Equity Growth % | - | -455.25% | 251.54% | 246.13% | -67.88% | 105.22% | -33.71% | -68.79% | 198.99% |
| Book Value per Share | -0.28 | -23.51 | 24.45 | 98.80 | 25.61 | 46.60 | 20.63 | 4.91 | 8.19 |
| Total Shareholders' Equity | -4.75M | -26.37M | 39.96M | 138.31M | 44.42M | 91.17M | 60.43M | 18.86M | 56.39M |
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | 1K | 1K | 1K |
| Retained Earnings | -18.01M | -39.11M | -85.19M | -177.07M | -286.07M | -316.68M | -428.31M | -489.63M | -482.46M |
| Treasury Stock | 0 | -952K | -952K | -952K | -952K | -952K | -952K | -952K | -952K |
| Accumulated OCI | 0 | -3.19M | -5.48M | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 92.27M | -24.17M | -51.72M | -73.64M | -87.39M | -10.85M | -45.75M | -84.11M | -58.45M |
| Operating CF Margin % | 1315.38% | -372.75% | -475.26% | -331.13% | -359.84% | -9.39% | -182.3% | -172.62% | -85.08% |
| Operating CF Growth % | - | -126.19% | -114.01% | -42.37% | -18.67% | 87.58% | -321.57% | -83.84% | 30.52% |
| Net Income | -8.25M | -21.1M | -46.04M | -92.88M | -109.01M | -30.6M | -111.64M | -61.32M | 7.17M |
| Depreciation & Amortization | 640K | 1.44M | 2.35M | 5.32M | 9.81M | 10.2M | 9M | 8.26M | 4.58M |
| Stock-Based Compensation | 0 | 419K | 2.45M | 0 | 13.79M | 16.51M | 19.2M | 14.04M | 12.6M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 1.37M | 174K | 14K | 16.28M | 35K | -26.55M | 13.57M | -3.6M | -28.79M |
| Working Capital Changes | 99.72M | -5.09M | -10.51M | -2.36M | -2.01M | 19.58M | 24.11M | -41.49M | -54M |
| Change in Receivables | 0 | 0 | -523K | -441K | -9.04M | 9.51M | -232K | -181K | 10.42M |
| Change in Inventory | 0 | 0 | -5.95M | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 82K | 864K | -673K | 667K | -1.46M | 867K | 153K | 1.51M | -2.1M |
| Cash from Investing | -2.08M | -5.51M | -15.66M | -24.67M | -5.03M | -5.8M | -3.32M | 5.83M | -215K |
| Capital Expenditures | -2.08M | -5.57M | -15.68M | -24.67M | -5.03M | -5.05M | -3.32M | -2.28M | -250K |
| CapEx % of Revenue | 29.58% | 85.83% | 144.06% | 110.92% | 20.72% | 4.37% | 13.22% | 4.67% | 0.36% |
| Acquisitions | 0 | 50K | 15K | 0 | 0 | 0 | 0 | 8M | 60K |
| Investments | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 50K | 15K | 0 | 0 | -750K | 0 | 107K | -25K |
| Cash from Financing | -12.38M | -937K | 107.78M | 176M | 1.33M | 70.52M | 94.98M | 5.39M | 50.45M |
| Debt Issued (Net) | 0 | 0 | 0 | 39.55M | 0 | 2.47M | 19.8M | 0 | -37K |
| Equity Issued (Net) | 49K | -952K | 1000K | 1000K | 0 | 1000K | 1000K | 1000K | 1000K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | -952K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -12.43M | 15K | -1.97M | 0 | 1.33M | 7.57M | 835K | 401K | 249K |
| Net Change in Cash | 77.82M | -30.62M | 40.39M | 77.69M | -91.09M | 53.87M | 45.91M | -72.9M | -8.21M |
| Free Cash Flow | 90.2M | -29.73M | -67.4M | -98.3M | -92.42M | -16.66M | -49.07M | -86.39M | -58.7M |
| FCF Margin % | 1285.8% | -458.57% | -619.32% | -442.05% | -380.55% | -14.42% | -195.52% | -177.3% | -85.44% |
| FCF Growth % | - | -132.96% | -126.68% | -45.85% | 5.99% | 81.98% | -194.62% | -76.05% | 32.06% |
| FCF per Share | 5.39 | -26.51 | -41.24 | -70.22 | -53.28 | -8.51 | -16.75 | -22.49 | -8.53 |
| FCF Conversion (FCF/Net Income) | -11.18x | 1.15x | 1.12x | 0.79x | 0.80x | 0.35x | 0.41x | 1.37x | -8.15x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 68K | 824K | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | - | -677.46% | -104.2% | -119.3% | -45.14% | -147.28% | -154.66% | 19.05% |
| Gross Margin | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% |
| Net Margin | -117.62% | -325.45% | -423.02% | -417.65% | -448.86% | -26.49% | -444.8% | -125.84% | 10.43% |
| Debt / Equity | - | - | - | - | 0.24x | 0.10x | 0.41x | 1.66x | 0.53x |
| Interest Coverage | - | - | - | -479.14x | - | -298.30x | -56.08x | -19.61x | -14.68x |
| FCF Conversion | -11.18x | 1.15x | 1.12x | 0.79x | 0.80x | 0.35x | 0.41x | 1.37x | -8.15x |
| Revenue Growth | - | -7.57% | 67.84% | 104.34% | 9.21% | 375.72% | -78.28% | 94.15% | 40.98% |
Explore detailed financial history, valuation models, and returns analysis
DCF models, peer multiples & analyst estimates
Historical returns with dividends reinvested
Yield, growth, payout safety & DRIP calculator
EPS trends, net income & profitability analysis
Long-term charts & historical price data
Sales growth patterns & revenue breakdown
30 years of valuation, profitability & efficiency metrics